© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
How to Spot A Phone Scam: Protecting Yourself in the Digital Age
News
20/07/2023How to Spot A Phone Scam: Protecting Yourself in the Digital Age

When your phone starts ringing with an unknown number flashing on the screen, it's tempting to answer, especially if you're expecting an important call. But did you know that answering such calls can sometimes be dangerous

Read Full PostRead - Eye Icon
Revolutionizing Digital Healthcare Services: A Comprehensive Overview
News
23/10/2023Revolutionizing Digital Healthcare Services: A Comprehensive Overview

In the dynamic landscape of digital healthcare services, a pioneering company leads the charge in healthcare innovation. With a holistic approach to digital health, they offer a wide range of services, ensuring their clients have the necessary tools to th

Read Full PostRead - Eye Icon
3 Business Benefits of Transitioning to the Hybrid Cloud
Innovation
26/07/20223 Business Benefits of Transitioning to the Hybrid Cloud

Cloud computing is becoming more popular as it assists companies in processing large volumes of data, allowing them to adapt quickly and cater to the business’s and its employees’ ever-changing needs. It also facilitates global deployment, paving the way f

Read Full PostRead - Eye Icon
Work Better, Not More: How to Improve Your Workflow at Home
Strategy
15/10/2020Work Better, Not More: How to Improve Your Workflow at Home

Being a remote worker can cause you to feel like you never actually have time off. You may find yourself replying to emails when you're in bed, or texting a coworker about a project while you're cooking dinner. For workaholics and perfectionists, the pressure

Read Full PostRead - Eye Icon
Enhancing Transparency And Trust: The Value Of Independent Audit And Assurance Services
Finance
11/07/2023Enhancing Transparency And Trust: The Value Of Independent Audit And Assurance Services

In the intricate world of business and financial systems, establishing trust and maintaining transparency has never been more vital.

Read Full PostRead - Eye Icon
Five Strategy Tips For Business Event Planning
News
30/03/2022Five Strategy Tips For Business Event Planning

Events are a critical part of the life of a business. Most businesses are launched with an event and host numerous others throughout their life. These events help businesses generate leads or land new prospects.

Read Full PostRead - Eye Icon
Advanced Enterprise Communication Solution
Innovation
09/04/2024Advanced Enterprise Communication Solution

Since its inception in 2002, CallTower has remained dedicated to delivering the world’s most advanced communications with its industry-leading Unified Communications as a Service (UCaaS), Contact Center as a Service (CCaaS) and Collaboration solutions.

Read Full PostRead - Eye Icon
The Findis Group Acquires Desamais Distribution
M&A
31/07/2015The Findis Group Acquires Desamais Distribution

The Findis Group Acquires Desamais Distribution

Read Full PostRead - Eye Icon
KPMG Capital Announces Equity Stake in Label Insight
Finance
11/02/2016KPMG Capital Announces Equity Stake in Label Insight

KPMG Capital today announced it has taken an equity stake in Label Insight, a leading provider of software-as-a-service (SaaS) data solutions providing powerful insights and strengthening the connections between Consumer Packaged Goods (CPG) brands, retailers



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow